<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02815735</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-68 (VISA-407)</org_study_id>
    <nct_id>NCT02815735</nct_id>
  </id_info>
  <brief_title>Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses</brief_title>
  <official_title>Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the subjective performance of the comfilcon A contact
      lens against lotrafilcon B contact lens after 4 weeks of reusable lens wear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a 80 subject, randomized, bilateral, double-masked, dispensing, cross-over study
      comparing comfilcon A versus lotrafilcon B lenses over 4 weeks of daily wear for each lens
      pair.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
    <description>Comfort (insertion, end of the day, and overall) for habitual lenses assessed at baseline and comfilcon A and lotrafilcon B lenses assessed at 2 weeks and 4 weeks. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort During the Day</measure>
    <time_frame>Days 3, 12, 26</time_frame>
    <description>Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message at days 3,12, and 26 at hours 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>comfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>comfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B</intervention_name>
    <description>contact lens</description>
    <arm_group_label>lotrafilcon B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spherical distance CL (Contact Lens) prescription between -1.00 and -6.00D (Diopter)
             OR in both eyes (inclusive)

          -  Adapted soft CL wearers (i.e. &gt;1 month) who are reusable lens wearers*

          -  Spectacle cylinder 0.75D in both eyes

          -  Correctable to 6/9 in both eyes

          -  Be between 18 and 34 years of age (inclusive)

          -  Able to read, comprehend and sign an informed consent

          -  Own a mobile phone and be able to respond to SMS survey during the period 8am - 8pm

          -  Willing to comply with the wear and study visit schedule

        Exclusion Criteria:

        Any of the following will render a subject ineligible for inclusion:

          -  Existing wearer of daily disposable contact lenses

          -  Known allergy to Opti-Free PureMoist multipurpose solution

          -  Any active corneal infection, injury or inflammation

          -  Systemic or ocular allergies, which might interfere with CL wear

          -  Systemic disease, which might interfere with CL wear

          -  Ocular disease, which might interfere with CL wear

          -  Strabismus or amblyopia

          -  Subjects who have undergone corneal refractive surgery

          -  Subjects with keratoconus or other severe corneal irregularity contraindicating lens
             wear

          -  Pregnant, planning a pregnancy or lactating

          -  Use of systemic/topical medication contraindicating CL wear

          -  Diabetic

          -  Site employees or family members of investigators

          -  Participation in any concurrent trial or in the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Young</last_name>
    <role>Study Director</role>
    <affiliation>Visioncare Research Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eyesite</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG1 1EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brock and Houlford</name>
      <address>
        <city>Chew Magna</city>
        <state>Bristol</state>
        <zip>BS40 8PR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tempany's Boutique Opticians</name>
      <address>
        <city>Broadstone</city>
        <state>Dorset</state>
        <zip>BH18 8DP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chalmers Opticians</name>
      <address>
        <city>Cardiff</city>
        <state>Glamorgan</state>
        <zip>CF24 3RQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leightons</name>
      <address>
        <city>St Albans</city>
        <state>Hertfordshire</state>
        <zip>AL1 3LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Gould Opticians</name>
      <address>
        <city>Rawtenstall</city>
        <state>Lancashire</state>
        <zip>BB4 7QN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrold Opticians</name>
      <address>
        <city>Uxbridge</city>
        <state>Middlesex</state>
        <zip>UB8 1JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boots Opticians Ltd</name>
      <address>
        <city>Birmingham</city>
        <state>Warwickshire</state>
        <zip>B4 7TB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Visioncare Research Ltd.</name>
      <address>
        <city>Farnham</city>
        <zip>GU9 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <results_first_submitted>March 28, 2017</results_first_submitted>
  <results_first_submitted_qc>March 28, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 8, 2017</results_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Four subjects were not dispensed lenses due to screen failure. Seven subjects discontinued from the study due to the investigational site withdrawing from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Comfilcon A, Then Lotrafilcon B</title>
          <description>Participants wear comfilcon A lens, then lotrafilcon B for 4 weeks during the cross over study.
comfilcon A: contact lens
lotrafilcon B: contact lens</description>
        </group>
        <group group_id="P2">
          <title>Lotrafilcon B, Then Comfilcon A</title>
          <description>Participants wear lotrafilcon B lens, then comfilcon A lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens
comfilcon A: contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (4 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Discomfort</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor fitting characteristics</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention (4 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Participants</title>
          <description>Participants wear comfilcon A and lotrafilcon B lens for 4 weeks during the cross over study.
comfilcon A: contact lens
lotrafilcon B: contact lens</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="74"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.5" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Comfort (insertion, end of the day, and overall) for habitual lenses assessed at baseline and comfilcon A and lotrafilcon B lenses assessed at 2 weeks and 4 weeks. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
        <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual (Baseline)</title>
            <description>Habitual data assessed at baseline.</description>
          </group>
          <group group_id="O2">
            <title>Comfilcon A (2 Weeks)</title>
            <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Lotrafilcon B (2 Weeks)</title>
            <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
          </group>
          <group group_id="O4">
            <title>Comfilcon A (4 Weeks)</title>
            <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
          </group>
          <group group_id="O5">
            <title>Lotrafilcon B (4 Weeks)</title>
            <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Comfort (insertion, end of the day, and overall) for habitual lenses assessed at baseline and comfilcon A and lotrafilcon B lenses assessed at 2 weeks and 4 weeks. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="71"/>
                <count group_id="O3" value="69"/>
                <count group_id="O4" value="70"/>
                <count group_id="O5" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort on insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.90" spread="1.38"/>
                    <measurement group_id="O2" value="9.03" spread="1.10"/>
                    <measurement group_id="O3" value="8.70" spread="1.57"/>
                    <measurement group_id="O4" value="8.74" spread="1.25"/>
                    <measurement group_id="O5" value="8.60" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.86" spread="1.38"/>
                    <measurement group_id="O2" value="8.13" spread="1.69"/>
                    <measurement group_id="O3" value="8.43" spread="1.54"/>
                    <measurement group_id="O4" value="8.11" spread="1.57"/>
                    <measurement group_id="O5" value="8.24" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End-of-Day Comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.03" spread="1.78"/>
                    <measurement group_id="O2" value="7.31" spread="2.21"/>
                    <measurement group_id="O3" value="7.45" spread="2.23"/>
                    <measurement group_id="O4" value="7.23" spread="2.17"/>
                    <measurement group_id="O5" value="7.34" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort During the Day</title>
        <description>Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message at days 3,12, and 26 at hours 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
        <time_frame>Days 3, 12, 26</time_frame>
        <population>Missing data from one participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Day 3)</title>
            <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B (Day 3)</title>
            <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
          </group>
          <group group_id="O3">
            <title>Comfilcon A (Day 12)</title>
            <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
          </group>
          <group group_id="O4">
            <title>Lotrafilcon B (Day 12)</title>
            <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
          </group>
          <group group_id="O5">
            <title>Comfilcon A (Day 26)</title>
            <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
          </group>
          <group group_id="O6">
            <title>Lotrafilcon B (Day 26)</title>
            <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort During the Day</title>
          <description>Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message at days 3,12, and 26 at hours 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm. Scale 0-10, 0=painful, 10=can't feel the lenses.</description>
          <population>Missing data from one participant.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="69"/>
                <count group_id="O3" value="72"/>
                <count group_id="O4" value="70"/>
                <count group_id="O5" value="70"/>
                <count group_id="O6" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>8:00 am</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="69"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="70"/>
                    <count group_id="O5" value="70"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.98" spread="1.34"/>
                    <measurement group_id="O2" value="8.78" spread="1.60"/>
                    <measurement group_id="O3" value="8.67" spread="1.21"/>
                    <measurement group_id="O4" value="8.96" spread="1.26"/>
                    <measurement group_id="O5" value="8.78" spread="1.00"/>
                    <measurement group_id="O6" value="8.59" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12:00 pm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="69"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="70"/>
                    <count group_id="O5" value="70"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.94" spread="1.48"/>
                    <measurement group_id="O2" value="8.95" spread="1.22"/>
                    <measurement group_id="O3" value="8.59" spread="1.26"/>
                    <measurement group_id="O4" value="8.73" spread="1.41"/>
                    <measurement group_id="O5" value="8.72" spread="1.39"/>
                    <measurement group_id="O6" value="8.60" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4:00 pm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="68"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="70"/>
                    <count group_id="O5" value="70"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.51" spread="1.58"/>
                    <measurement group_id="O2" value="8.74" spread="1.31"/>
                    <measurement group_id="O3" value="8.51" spread="1.49"/>
                    <measurement group_id="O4" value="8.70" spread="1.45"/>
                    <measurement group_id="O5" value="8.31" spread="1.56"/>
                    <measurement group_id="O6" value="8.27" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8:00 pm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="68"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="70"/>
                    <count group_id="O5" value="70"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.15" spread="1.94"/>
                    <measurement group_id="O2" value="8.14" spread="1.59"/>
                    <measurement group_id="O3" value="7.91" spread="1.89"/>
                    <measurement group_id="O4" value="8.25" spread="1.77"/>
                    <measurement group_id="O5" value="7.85" spread="1.70"/>
                    <measurement group_id="O6" value="7.89" spread="1.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Comfilcon A</title>
          <description>Participants wear comfilcon A lens for 4 weeks during the cross over study.
comfilcon A: contact lens</description>
        </group>
        <group group_id="E2">
          <title>Lotrafilcon B</title>
          <description>Participants wear lotrafilcon B lens for 4 weeks during the cross over study.
lotrafilcon B: contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Manager Global Medical Scientific Affairs</name_or_title>
      <organization>CooperVision Inc.</organization>
      <phone>925 621-3761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

